Valued at a market cap of $18.2 billion, Quest Diagnostics Incorporated (DGX) provides diagnostic testing and services in the ...

The global personal genome testing market is on a remarkable growth trajectory, projected to soar to USD 4,468 million by 2032, up from USD 1,545.5 million in 2022. This growth reflects a robust CAGR ...

The firm said that investors provided better-than-expected backing as the company anticipates growing use of its digital pathology platform in 2025.

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the testing & diagnostics services stocks, including ...

The Company’s total aggregate Q1 2025 revenue of approximately $12.1 million (based on a BTC price of $83,500 as of March 31, 2025, per CoinMarketCap) represents an increase in quarterly revenue of ...

As antibody-drug conjugates (ADCs) advance in precision oncology, diagnostics play a vital role in identifying eligible patients, validating biomarkers and supporting regulatory approval. A ...

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.

The Quest Diagnostics office, at 1074 Idaho St., will have two phlebotomists when fully staffed and expects to draw blood ...

In addition to its year end 2024 financial results, the Company will also provide an update on its operations at that time. Digi Power X is an innovative energy infrastructure company that develops ...

As part of this effort, the college has allocated Rs 16 crore to purchase new medical equipment for treatment and diagnostics. A Green Corridor ... visits daily. The expansion of healthcare services ...

Achieved claims expansion for transplant rejection monitoring ... He also has been an advisor or a physician leader with ...

The Government of Canada acquired TMX from Kinder Morgan in 2018. This was a serious and necessary investment made in the national interest. The completion of this important infrastructure project is ...